Affordable Access

deepdyve-link
Publisher Website

A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older, HIV-Positive Patients.

Authors
  • McNicholl, I R1
  • Gandhi, M2
  • Hare, C Bradley3
  • Greene, M4
  • Pierluissi, E5
  • 1 HIV Medical Affairs, Gilead Sciences, Inc. Foster City, California.
  • 2 Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), California.
  • 3 Infectious Diseases, Kaiser Permanente, San Francisco, California.
  • 4 Division of Geriatrics, Department of Medicine, University of California at San Francisco, San Francisco, California.
  • 5 Division of Geriatrics and Hospital Medicine, Department of Medicine, San Francisco General Hospital, University of California at San Francisco, San Francisco, California.
Type
Published Article
Journal
Pharmacotherapy
Publication Date
Oct 10, 2017
Identifiers
DOI: 10.1002/phar.2043
PMID: 29023938
Source
Medline
Keywords
License
Unknown

Abstract

Results suggest that targeting individuals with 11 or more chronic medications would have the highest yield and greatest impact. Pharmacist-led review of medication prescribing employing Beers and STOPP criteria revealed a large number of PIP, many amenable to immediate clinical pharmacist intervention. This article is protected by copyright. All rights reserved.

Report this publication

Statistics

Seen <100 times